Search result for 'voluntary action indicated'

Dr Reddy''s Srikakulam facility gets Voluntary Action Indicated (VAI) status from USFDA after inspection. Inspection officially closed.

Natco Pharma's Kothur unit in Hyderabad receives 'voluntary action indicated' classification from the USFDA after inspection.

Biocon Biologics' Bengaluru drug substance facility has been classified as voluntary action indicated by the USFDA following a cGMP inspection. The action relates to rh-Insulin (rhI) drug substance...

Dr Reddy's Laboratories received a Voluntary Action Indicated (VAI) establishment inspection report (EIR) from the USFDA for its API facility in Srikakulam, Andhra Pradesh.

Dr Reddy's Laboratories has received an Establishment Inspection Report (EIR) from the USFDA for its formulations manufacturing units in Visakhapatnam, classifying the facilities to voluntary...

Biocon's Q1 profit jumps six-fold to Rs 660 crore, driven by a one-time gain from the Biocon Biologics and Eris Lifesciences collaboration. Revenue also grew slightly.

Cipla expects to start supplying the US market from its China facility in the second half of FY 2024-25 after receiving USFDA approval. The company is also working to resolve issues with its...

Jubilant Pharma's Roorkee unit receives a Voluntary Action Indicated (VAI) classification from the USFDA, indicating acceptable compliance with cGMP.

Dr Reddy's Laboratories' Hyderabad R&D center receives VAI classification from USFDA following inspection. The classification indicates no immediate regulatory action.